Australian Cancer Technology Limited (“AustCancer”) (ASX: ACU) today announced that its US subsidiary, ACT (USA), has signed a distribution deal with Rochester Drug Cooperative, which will see the revisys(TM) range of nutritional supplements stocked in hundreds of pharmacies in the country’s northeast. Rochester Drug Cooperative is an independently owned wholesale drug cooperative, servicing more than 800 community retail pharmacies, long-term care pharmacies and home health care stores in New York State, Pennsylvania and New Jersey.
